Pfizer may be the first drugmaker to file for US regulatory authorization for its Covid-19 vaccine, which it says is 95% effective with no serious side effects. This comes right on the heels of news out of Moderna, which says its vaccine also stands at over 94%. With hopes rising that we may see a vaccine in distribution by the end of the year, we speak to Sam Fazeli, Senior Healthcare Analyst at Bloomberg Intelligence, about whether this is truly a cause for excitement.
Image Credit: Shutterstock

China’s Humanoid Robot Boom: Hype vs Reality
11:25

Why Peace Remains Elusive In Southern Thailand
09:03

What to Watch at PAS's 72nd Muktamar
11:23